Nutriband Inc. (NTRB) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Nutriband Inc. (NTRB) closed at USD 6.32 on 2026-10-14, a change of -18.6 % over the past year, with a market capitalization of USD 76.22M.

Nutriband Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Nutriband Inc. key figures

Previous close

USD 6.32 (2026-10-14)

1-year change

-18.6 %

Market cap

USD 76.22M

Enterprise value

USD 73.02M

P/E ratio (trailing)

-11.83

P/E ratio (forward)

-27.26

EPS (trailing)

-0.53

EPS (forward)

-0.23

PEG ratio

n/a

Price to book

14.32

Revenue growth

-29.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.10

Employees

n/a

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Nutriband Inc. and compare it with other stocks.